「q」の検索結果
392件：1～5件目を表示
-
アイファガン点眼液0.1％
関する理化学的知見 一般名：ブリモニジン酒石酸塩 （Brimonidine Tartrate） 〔JAN〕 化学名：5-Bromo- - （4,5-dihydro-1 -imidazol-2-yl） quinoxalin-6-amine mono- （2 ,3 ） -tartrate 構造式： 分子式：C11H10BrN5・C4H6O6 分子量：442.22 性 状：ブリモニジン酒石酸塩は白色∼微...
https://www.senju.co.jp/sites/default/files/product_other_file/2024-06/aiphagan_202406_C2.pdf -
ials in Japan for the novel Dry Eye Disease treatment, SJP-0132 Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter: Senju) is developing a compound ...
https://www.senju.co.jp/sites/default/files/content_news/2024-07/ENG_20240716_0.pdf -
Data And Statistics | About Senju | SENJU Pharmaceutical
Sales Revenue. Operating Profit and Ordinary Profit 2020.3 2021.3 2022.3* 2023.3* 2024.3* Sales Revenue 41.2 40.7 40.8 46.4 48.9 Operating Profit 2.2 5.4 6.9 7.4 7.1 Ordinary Profit 4.3 8.0 9.1 8.7 9.
https://www.senju.co.jp/english/about/sales.html -
oval in Japan for the novel Dry Eye Disease treatment, SJP-0132 Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter: Senju) is developing a TRPV1 ant...
https://www.senju.co.jp/sites/default/files/content_news/2025-01/ENG_20250117.pdf -
oval in Japan for the novel Dry Eye Disease treatment, SJP-0132 Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter: Senju) is developing a TRPV1 ant...
https://www.senju.co.jp/sites/default/files/content_news/2025-01/ENG_20250117_0.pdf